Brazil’s CADE set to rule on Novamed-Medley deal, other cases
( November 12, 2026, 13:16 GMT | Official Statement) -- MLex Summary: Brazil’s competition authority is expected to vote on Nov. 18 on Novamed’s acquisition of Medley in the pharmaceutical sector. The Administrative Council for Economic Defense, or CADE, is also set to decide on Unimed Blumenau’s acquisition of a hospital in Santa Catarina and an appeal related to the SulAmérica-Rede D’Or investigation, among other cases.Brazil’s Official Journal follows (in Portuguese):...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.